Long-term Survival and Influencing Factors of Patients With Pulmonary Arterial Hypertension and Diabetes
NCT ID: NCT07082933
Last Updated: 2025-07-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
5000 participants
OBSERVATIONAL
2025-08-01
2027-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Screening and Analysis of Plasma Biomarkers in Irreversible PAH-CHD
NCT02267200
Connective Tissue Disease Patients With Pulmonary Hypertension
NCT05980728
Registry for Chronic Obstructive Pulmonary Disease With Pulmonary Thromboembolism in China
NCT03185377
Frequency of Diagnostic Symptomatic Pulmonary Embolism's in Patients Hospitalized for Clinical Exacerbation of Chronic Obstructive Pulmonary Disease (COPD)
NCT02035293
Thrombolytic and Interventional Treatment of Pulmonary Embolism
NCT03886194
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
pulmonary arterial hypertension combined with diabetes
patients with pulmonary arterial hypertension and diabetes
Standard medical treatment
Standard medical treatment
pulmonary arterial hypertension without comorbid diabetes
pulmonary arterial hypertension without comorbid diabetes
Standard medical treatment
Standard medical treatment
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Standard medical treatment
Standard medical treatment
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients diagnosed with pulmonary hypertension by community-level and/or higher-level medical institutions.
Exclusion Criteria
* Other physical conditions judged by the researchers as making the patients ineligible to participate in the clinical study.
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Xijing Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Yue Zhang, Doctor
Role: PRINCIPAL_INVESTIGATOR
Department of Health Management, Xijing Hospital, Air Force Medical University
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
KY-20252240
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.